Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1992
Regulation of the respiratory burst by cyclic 3',5'-AMP, an association with inhibition of arachidonic acid releaseC P Nielson, C Bayer, S Hodson, et al.
The Journal of Allergy and Clinical Immunology|November 1, 1990
Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burstC P Nielson, R E Vestal, R J Sturm, et al.
The American Review of Respiratory Disease|January 1, 1988
Polymorphonuclear leukocyte inhibition by therapeutic concentrations of theophylline is mediated by cyclic-3',5'-adenosine monophosphateC P Nielson, J J Crowley, M E Morgan, et al.
The Journal of Allergy and Clinical Immunology|March 1, 1995
Beta-adrenergic regulation of the eosinophil respiratory burst as detected by lucigenin-dependent luminescenceN E Hadjokas, J J Crowley, C R Bayer, et al.
British Journal of Pharmacology|June 1, 1986
Beta-adrenoceptor-mediated modulation of calcium ionophore activated polymorphonuclear leucocytesJ A Mack, C P Nielson, D L Stevens, et al.
The Journal of Allergy and Clinical Immunology|November 1, 1992
Impaired beta-adrenoceptor function, increased leukocyte respiratory burst, and bronchial hyperresponsivenessC P Nielson, J J Crowley, R E Vestal, et al.
The Journal of Allergy and Clinical Immunology|October 1, 1986
Therapeutic concentrations of theophylline and enprofylline potentiate catecholamine effects and inhibit leukocyte activationC P Nielson, J J Crowley, B J Cusack, et al.
Clinical Pharmacology and Therapeutics|March 1, 1987
Additive effect of theophylline on the cardiac response to isoproterenolB J Cusack, C P Nielson, M E Morgan, et al.
Breast Cancer Research and Treatment|November 5, 1998
CD40 is functionally expressed on human breast carcinomas: variable inducibility by cytokines and enhancement of Fas-mediated apoptosisD G Wingett, R E Vestal, K Forcier, et al.
American Journal of Respiratory and Critical Care Medicine|August 1, 1996
Controlled trial of oral prednisone in outpatients with acute COPD exacerbationW H Thompson, C P Nielson, P Carvalho, et al.
Pageof 3